Hemispherx Biopharma (HEB) Doubles Q1 Loss to 2c/Share
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Price: $1.80 --0%
Financial Fact:
Total costs and expenses: 2.83M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total costs and expenses: 2.83M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Hemispherx Biopharma, Inc. (NYSE: HEB) reported Q1 EPS of ($0.02), versus ($0.01) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
